Also it will cost less to conduct trials in US and Europe because of the past 2 news. They need not raise cash and they are sufficiently funded now.
If the interim readouts are looking very positive, FDA may grant approval as there is an urgency.
Also it will cost less to conduct trials in US and Europe...
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
0.010(6.25%) |
Mkt cap ! $82.65M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 17.0¢ | 15.5¢ | $145.3K | 876.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 38307 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 302337 | 3 |
View Market Depth
| Last trade - 15.51pm 23/08/2024 (20 minute delay) ? |
| PAA (ASX) Chart |